SECsense Logo

Moleculin Biotech, Inc. 8-K Report: Key Corporate Updates for February 2025

$MBRX
Form 8-K
Filed on: 2025-02-10
Source
Moleculin Biotech, Inc. 8-K Report: Key Corporate Updates for February 2025

Based on the provided section of the financial report, here are the key insights and information extracted:

  1. Entity Information:
  • Company Name: Moleculin Biotech, Inc.
  • State of Incorporation: Delaware (DE)
  • CIK Number: 0001659617
  • SEC Central Index Key (CIK): 0001659617
  1. Report Details:
  • Form Type: 8-K (a report used to disclose major events that shareholders should know about)
  • Filing Date: February 9, 2025
  • Period Covered: The report covers the exact date of February 9, 2025.
  1. Financial Information:
  • Stock Information:
    • Type of Stock: Common Stock
    • Par Value: $0.001 per share
    • Ticker Symbol: MBRX
    • Exchange: NASDAQ
  1. Contact Information:
  • Address: 5300 Memorial Drive, Suite 950, Houston, TX 77007
  • Phone Number: 713-300-5160

Summary:

Moleculin Biotech, Inc. filed an 8-K report on February 9, 2025, disclosing relevant corporate information. The company is publicly traded on NASDAQ under the ticker MBRX, with a par value of $0.001 per share for its common stock. The filing provides essential identifiers and contact information for stakeholders.